RECRUITINGOBSERVATIONAL
Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"
About This Trial
The purpose of this survey is to evaluate the long-term safety and efficacy of leuprorelin acetate injection kit 11.25 mg in patients with spinal and bulbar muscular atrophy (SBMA) in the routine clinical setting.
Who May Be Eligible (Plain English)
Who May Qualify:
- All SBMA patients who have been confirmed as receiving the drug
Who Should NOT Join This Trial:
- None
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* All SBMA patients who have been confirmed as receiving the drug
Exclusion Criteria:
* None
Treatments Being Tested
DRUG
Leuprorelin Acetate
Leuprorelin Acetate Injection Kit
Locations (1)
Takeda Selected Site
Tokyo, Japan